Wakamoto製藥
4512
Kids Smile控股
7084
T.O.控股
9812
Land株式會社
8918
GMO AD Partners
4784
(FY)2024/10/31 | (Q2)2024/04/30 | (Q1)2024/01/31 | (FY)2023/10/31 | (Q4)2023/10/31 | (Q3)2023/07/31 | (Q2)2023/04/30 | (Q1)2023/01/31 | (FY)2022/10/31 | (Q4)2022/10/31 | |
---|---|---|---|---|---|---|---|---|---|---|
營業總收入 | 9.28%32.07億 | 3.55%8.51億 | 0.34%6.3億 | 19.47%29.34億 | 21.13%8.96億 | 0.43%5.88億 | 37.58%8.22億 | 17.77%6.28億 | 11.84%24.56億 | 21.89%7.4億 |
主營業務成本 | 15.00%12.75億 | 17.42%3.28億 | 3.89%2.6億 | 28.28%11.09億 | 21.27%3.54億 | 19.93%2.26億 | 31.80%2.79億 | 44.90%2.5億 | 4.26%8.64億 | 8.41%2.92億 |
毛利 | 5.81%19.32億 | -3.59%5.23億 | -2.00%3.71億 | 14.69%18.26億 | 21.04%5.43億 | -8.81%3.62億 | 40.75%5.42億 | 4.81%3.78億 | 16.44%15.92億 | 32.61%4.49億 |
營業費用 | -5.01%19.84億 | -8.37%4.82億 | -4.52%5.05億 | 8.77%20.88億 | -2.34%5.02億 | 3.82%5.31億 | 15.55%5.27億 | 20.51%5.29億 | 41.60%19.2億 | 39.43%5.14億 |
營業利潤 | 80.33%-5,162.4萬 | 154.57%4,048.4萬 | 10.87%-1.34億 | 19.97%-2.62億 | 162.73%4,102.2萬 | -47.63%-1.69億 | 122.62%1,590.3萬 | -93.43%-1.5億 | -2,983.91%-3.28億 | -115.38%-6,539.4萬 |
營業外利息收入與支出淨額 | 33.61%-872.6萬 | 68.75%-230萬 | 2.09%-216萬 | -147.95%-1,314.4萬 | -16.75%-178.4萬 | -40.71%-179.4萬 | -524.26%-736萬 | -67.25%-220.6萬 | -44.56%-530.1萬 | -48.64%-152.8萬 |
營業外利息收入 | 1,593.75%54.2萬 | 641.18%18.4萬 | 297.96%19.5萬 | -64.04%3.2萬 | -55.56%8,000 | -47.06%9,000 | -230.77%-3.4萬 | 75.00%4.9萬 | -59.55%8.9萬 | -67.27%1.8萬 |
營業外利息支出 | -23.81%375.6萬 | -43.65%102.9萬 | -18.97%120.9萬 | 21.10%493萬 | -34.21%80萬 | -15.59%81.2萬 | 108.69%182.6萬 | 46.56%149.2萬 | 30.11%407.1萬 | 61.49%121.6萬 |
其他財務費用 | -33.16%551.2萬 | -73.55%145.5萬 | 50.20%114.6萬 | 525.17%824.6萬 | 200.61%99.2萬 | 200.30%99.1萬 | 1,566.67%550萬 | 131.91%76.3萬 | 74.01%131.9萬 | 0.00%33萬 |
投資淨收益 | -60.62%-252.5萬 | -350.77%-130.4萬 | -338.37%-61.5萬 | 53.55%-157.2萬 | -74.95%-90.8萬 | 1.50%-144.2萬 | 333.18%52萬 | 121.90%25.8萬 | 25.22%-338.4萬 | 46.60%-51.9萬 |
被指定為現金流套期的金融工具損益 | ||||||||||
終止確認可供出售金融資產損益 | ||||||||||
聯營企業及其他參股權益產生的收益 | ||||||||||
特殊收入(費用) | 71.80%-4,193.5萬 | -4,947.93%-1.49億 | 187.77%313.6萬 | 306.7萬 | -357.3萬 | |||||
減:其他特殊費用 | -586.14%-3,661.1萬 | ---- | ---- | 345.55%753.1萬 | --0 | ---- | ---- | ---- | ---306.7萬 | --357.3萬 |
減:勾銷 | -44.35%7,854.6萬 | ---- | ---- | --1.41億 | ---313.6萬 | ---- | ---- | ---- | --0 | --0 |
其他營業外收入(費用) | -15.46%954.7萬 | 4.49%570.3萬 | 17.52%91.9萬 | 38.75%1,129.3萬 | 405.37%207.2萬 | 305.03%298.1萬 | 111.80%545.8萬 | -82.29%78.2萬 | -83.42%813.9萬 | -99.07%41萬 |
稅前利潤 | 77.02%-9,526.4萬 | 193.25%4,258.3萬 | 10.33%-1.36億 | -27.40%-4.15億 | 161.67%4,353.8萬 | -192.39%-3.21億 | 121.01%1,452.1萬 | -99.86%-1.52億 | -722.59%-3.25億 | -692.17%-7,060.4萬 |
所得稅 | -79.63%634.9萬 | 0.58%34.9萬 | 50.00%51.9萬 | -23.08%3,116.4萬 | -25.80%2,909.2萬 | 127.56%137.9萬 | 11.22%34.7萬 | -10.36%34.6萬 | 174.85%4,051.3萬 | 166.82%3,920.9萬 |
除稅後利潤 | 77.20%-1.02億 | 197.95%4,223.4萬 | 10.19%-1.36億 | -21.81%-4.46億 | 113.16%1,444.7萬 | -192.03%-3.22億 | 120.41%1,417.5萬 | -99.30%-1.52億 | -443.91%-3.66億 | -255.54%-1.1億 |
持續經營利潤 | 77.20%-1.02億 | 197.97%4,223.4萬 | 10.19%-1.36億 | -21.81%-4.46億 | 113.16%1,444.6萬 | -192.03%-3.22億 | 120.41%1,417.4萬 | -99.30%-1.52億 | -443.91%-3.66億 | -255.54%-1.1億 |
歸屬于少數股東的淨利潤 | 0 | 0 | ||||||||
歸屬於母公司的淨利潤 | 77.20%-1.02億 | 197.95%4,223.4萬 | 10.19%-1.36億 | -21.81%-4.46億 | 113.16%1,444.7萬 | -192.03%-3.22億 | 120.41%1,417.5萬 | -99.30%-1.52億 | -439.12%-3.66億 | -255.19%-1.1億 |
優先股派息 | ||||||||||
其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
歸屬于普通股股東的淨利潤 | 77.20%-1.02億 | 197.95%4,223.4萬 | 10.19%-1.36億 | -21.81%-4.46億 | 113.16%1,444.7萬 | -192.03%-3.22億 | 120.41%1,417.5萬 | -99.30%-1.52億 | -439.12%-3.66億 | -255.19%-1.1億 |
總派息金額 | ||||||||||
基本每股收益 | 78.05%-31.97 | 146.58%13.34 | 16.96%-42.98 | -16.77%-145.68 | 117.77%6.65 | -181.49%-105.98 | 122.84%5.41 | -99.15%-51.76 | -438.75%-124.76 | -254.99%-37.43 |
稀釋每股收益 | 78.05%-31.97 | 185.86%13.2793 | 16.96%-42.98 | -16.77%-145.68 | 112.16%4.5522 | -181.49%-105.98 | 119.61%4.6453 | -99.15%-51.76 | -443.79%-124.76 | -257.40%-37.43 |
每股派息 | ||||||||||
貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |